본문 바로가기

Journals

  • Home
  • Cyber Information Center
  • Journals
Journals
Journal Corresponding Author Writer,Title,Journal,Publication;Year;Page:Volume(Impact Factor)
First Author
Oral microbial signatures underlying recurrence via PI3K/AKT/mTOR pathway modulation in oral squamous cell carcinoma Kim Mi Kyung
(Cancer Epidemiology Branch)

Kwack Da Woon
(Branch of Oral Maxillofacial Surgery)
. Oral microbial signatures underlying recurrence via PI3K/AKT/mTOR pathway modulation in oral squamous cell carcinoma. JOURNAL OF ORAL MICROBIOLOGY. 2025-09-20; 2025; 17(1):2560020~. IF 5.5 (2024)
Nurses’ Satisfaction and Demand for Stoma Care in the National Cancer Patient Home-Care Pilot Program Kim, Young Ae
(Division of Cancer Management Policy)


()
. Nurses’ Satisfaction and Demand for Stoma Care in the National Cancer Patient Home-Care Pilot Program. NURSING RESEARCH. 2025-09-18; 2025; 75(1):48~53. IF 2.2 (2024)
Long-term Survival Following Endoscopic Submucosal Dissection Versus Gastrectomy in Early Gastric Cancer Patients Aged 75 Years and Above: A National Retrospective Cohort Study in Korea Choi Kui son
(Department of Public Health & AI)

Lee Sang Won
(Data Curation & Construction Team)
. Long-term Survival Following Endoscopic Submucosal Dissection Versus Gastrectomy in Early Gastric Cancer Patients Aged 75 Years and Above: A National Retrospective Cohort Study in Korea. JOURNAL OF GASTRIC CANCER. 2025-09-18; 2025; 25(4):569~580. IF 3.8 (2024)
Prevalence of germline CHEK2 variants in East Asians and Koreans based on population genomic databases Sun-Young Kong
(Targeted Therapy Branch)


()
. Prevalence of germline CHEK2 variants in East Asians and Koreans based on population genomic databases. BREAST CANCER. 2025-09-16; 2025; 33:80~87. IF 2.9 (2024)
Hidden Burden of Alcohol Use Disorder in MASLD and MetALD: Clinical and Nomenclatural Implications Cho Yu Ri
(Targeted Therapy Branch)

Cho Yu Ri
(Targeted Therapy Branch)
. Hidden Burden of Alcohol Use Disorder in MASLD and MetALD: Clinical and Nomenclatural Implications. GUT AND LIVER. 2025-09-15; 2025; 19(5):637~638. IF 3.2 (2024)
Integrative transcriptomic analysis of Korean high-grade serous ovarian cancer Kim Jeong seon
(Department of Cancer Biomedical Science)

KimHyonDeog
(Department of Cancer Biomedical Science)
. Integrative transcriptomic analysis of Korean high-grade serous ovarian cancer. PLOS GENETICS. 2025-09-15; 2025; 21(9):e1011660~. IF 3.7 (2024)
Effectiveness and cost analysis of liposomal irinotecan in patients with pancreatic adenocarcinoma: a multicenter real-world study Woo Sang Myung
(Immuno-oncology Branch)

Kim, Young Ae
(Division of Cancer Management Policy)
. Effectiveness and cost analysis of liposomal irinotecan in patients with pancreatic adenocarcinoma: a multicenter real-world study. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY. 2025-09-13; 2025; 17:1~11. IF 4.2 (2024)
The emerging intertwined activities of metabolism and epigenetics unveils culprits and prospects in cancer Lindroth Anders Mikael
(Department of Cancer Biomedical Science)


()
. The emerging intertwined activities of metabolism and epigenetics unveils culprits and prospects in cancer. EXPERIMENTAL AND MOLECULAR MEDICINE. 2025-09-12; 2025; 57(9):1928~1939. IF 12.9 (2024)
Inequalities in breast cancer incidence and mortality in women with and without disabilities in South Korea: A population-based cohort study Oh J K
(Department of Public Health & AI)

Kang, Hee-Yeon
(Department of Public Health & AI)
. Inequalities in breast cancer incidence and mortality in women with and without disabilities in South Korea: A population-based cohort study. PREVENTIVE MEDICINE REPORTS. 2025-09-12; 2025; 59:103242~. IF 2.4 (2024)
Targeting TGF-β-Smad2/3-JNK1-mediated SIRT1 activity overcomes the chemoresistance of KRAS mutation lung cancer Shin, Dong Hoon
(Anticancer Resistance Branch )

Shin, Dong Hoon
(Anticancer Resistance Branch )
. Targeting TGF-β-Smad2/3-JNK1-mediated SIRT1 activity overcomes the chemoresistance of KRAS mutation lung cancer. EXPERIMENTAL AND MOLECULAR MEDICINE. 2025-09-12; 2025; 57(9):2022~2039. IF 12.9 (2024)
First page Prev paging 11 12 13 14 15 16 17 18 19 20 next paging last page